Johnson & Johnson
JNJ.DE News Today: Stay Updated with the Latest Johnson & Johnson News in Real Time
Find JNJ.DE news now at Meyka AI. Stay informed with the latest Johnson & Johnson stocks updates, including price news, market analysis, and expert insights.
PA8.F Stock Surges 62.5% in After-Hours Trading on April 15
PA8.F stock jumps 62.5% to €0.065 in after-hours session. Paion AG shows strong volume activity on XETRA. Analysis and market sentiment inside.
OTTR Insider Buying: 4 Executives Acquire Stock April 15, 2026
Otter Tail Corporation insiders acquire 4,900 shares on April 13. Nelson Tyler J, LeBeau, Clark, and Johnson file Form 3 and Form 4 disclosures.
Social Security COLA 2027 April 14: Inflation Surge Lifts Estimate
Social Security COLA 2027 rises to 3.2% on April 14 as inflation spikes, bringing higher adjustments for retirees.
JCHAC.NS Stock Flat at 1432.20 INR on NSE, April 14 2026
JCHAC.NS stock holds steady at 1432.20 INR on NSE. Meyka AI rates it B grade. Dividend yield 3.56%. Consumer cyclical sector.
Johnson & Johnson Q1 Earnings Preview: Pharma Growth in Focus Amid Legal Risks
Johnson & Johnson remains one of the leading global healthcare giants, and its upcoming Q1 earnings report is drawing strong attention from investors. The company has been undergoing a strategic transformation in recent years, increasingly focusing on higher-margin pharmaceutical and medical technology segments. While strong momentum in oncology and med-tech continues to support revenue growth,…
Immigration Judges Fired April 13: Trump’s Court Purge Accelerates
Trump administration fires immigration judges Roopal Patel and Nina Froes for blocking deportations, intensifying court system overhaul.
JNJ Analyst Rating Maintained at Overweight by Morgan Stanley April 2026
Morgan Stanley maintains JNJ analyst rating at Overweight, raises price target to $267 on April 10, 2026.
SEE Insider Trading: 12 Executives Sell Stock on April 9, 2026
Sealed Air insiders filed 12 dispositions on April 9, 2026. CEO, CFO, and board members sold shares via Form 4 filings.
Morgan Stanley Maintains Overweight on Johnson & Johnson (JNJ) Mar 2026
JNJ analyst rating: Morgan Stanley keeps Overweight on Johnson & Johnson on Mar 18, 2026